Stanley Lowenbraun
About
In The Last Decade
Stanley Lowenbraun
18 papers receiving 406 citations
Peers
Comparison fields: 5 of 56
- Oncology 295
- Epidemiology 188
- Pulmonary and Respiratory Medicine 165
- Pathology and Forensic Medicine 161
- Molecular Biology 82
Countries citing papers authored by Stanley Lowenbraun
This map shows the geographic impact of Stanley Lowenbraun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley Lowenbraun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley Lowenbraun more than expected).
Fields of papers citing papers by Stanley Lowenbraun
This network shows the impact of papers produced by Stanley Lowenbraun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley Lowenbraun. The network helps show where Stanley Lowenbraun may publish in the future.
Co-authorship network of co-authors of Stanley Lowenbraun
This figure shows the co-authorship network connecting the top 25 collaborators of Stanley Lowenbraun. A scholar is included among the top collaborators of Stanley Lowenbraun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley Lowenbraun. Stanley Lowenbraun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Antibiotic prophylaxis and infection resistance of massive tumor endoprostheses during chemotherapy. | 3 |
| 2 | 2 | |
| 3 | Anguidine: a broad phase II study of the Southeastern Cancer Study Group. | 15 |
| 4 | 12 | |
| 5 | 39 | |
| 6 | 53 | |
| 7 | Alternating non-cross-resistant drug combinations in the treatment of metastatic small-cell carcinoma of the lung. | 12 |
| 8 | 16 | |
| 9 | Combined modality treatment of localized small-cell lung carcinoma. A randomized prospective study of the Southeastern Cancer Study Group. | 5 |
| 10 | 83 | |
| 11 | cis-Dichlorodiammineplatinum(II) and hexamethylmelamine in the treatment of non-oat cell lung cancer: a pilot study of the Southeastern Cancer Study Group. | 2 |
| 12 | 31 | |
| 13 | 37 | |
| 14 | 54 | |
| 15 | 71 | |
| 16 | 17 | |
| 17 | 1 | |
| 18 | 52 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.